These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9454733)

  • 1. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi.
    Engel JC; Doyle PS; Palmer J; Hsieh I; Bainton DF; McKerrow JH
    J Cell Sci; 1998 Mar; 111 ( Pt 5)():597-606. PubMed ID: 9454733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi.
    Engel JC; Torres C; Hsieh I; Doyle PS; McKerrow JH
    J Cell Sci; 2000 Apr; 113 ( Pt 8)():1345-54. PubMed ID: 10725218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi.
    Barr SC; Warner KL; Kornreic BG; Piscitelli J; Wolfe A; Benet L; McKerrow JH
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5160-1. PubMed ID: 16304193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
    Chen YT; Brinen LS; Kerr ID; Hansell E; Doyle PS; McKerrow JH; Roush WR
    PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20856868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.
    Yong V; Schmitz V; Vannier-Santos MA; de Lima AP; Lalmanach G; Juliano L; Gauthier F; Scharfstein J
    Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: insights into naphthoquinone effects on growth and proteinase activity.
    Bourguignon SC; Cavalcanti DF; de Souza AM; Castro HC; Rodrigues CR; Albuquerque MG; Santos DO; da Silva GG; da Silva FC; Ferreira VF; de Pinho RT; Alves CR
    Exp Parasitol; 2011 Jan; 127(1):160-6. PubMed ID: 20647011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
    Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
    Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses.
    Lameiro RF; Montanari CA
    ChemMedChem; 2023 Mar; 18(6):e202200434. PubMed ID: 36692246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of cruzain: a therapeutic target for Chagas' disease.
    McGrath ME; Eakin AE; Engel JC; McKerrow JH; Craik CS; Fletterick RJ
    J Mol Biol; 1995 Mar; 247(2):251-9. PubMed ID: 7707373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Trypanosoma cruzi protease cruzain mediates immune evasion.
    Doyle PS; Zhou YM; Hsieh I; Greenbaum DC; McKerrow JH; Engel JC
    PLoS Pathog; 2011 Sep; 7(9):e1002139. PubMed ID: 21909255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
    Doyle PS; Zhou YM; Engel JC; McKerrow JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cruzain inhibitors for the treatment of Chagas' disease.
    Rogers KE; Keränen H; Durrant JD; Ratnam J; Doak A; Arkin MR; McCammon JA
    Chem Biol Drug Des; 2012 Sep; 80(3):398-405. PubMed ID: 22613098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
    Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
    Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Novel Inhibitors of Cruzain Cysteine Protease of
    Prates JLB; Lopes JR; Chin CM; Ferreira EI; Dos Santos JL; Scarim CB
    Curr Med Chem; 2024; 31(16):2285-2308. PubMed ID: 37888814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational approaches towards the discovery and optimisation of cruzain inhibitors.
    Santos VC; Ferreira RS
    Mem Inst Oswaldo Cruz; 2022; 117():e210385. PubMed ID: 35293427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
    Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.
    Santos CC; Sant'anna C; Terres A; Cunha-e-Silva NL; Scharfstein J; de A Lima AP
    J Cell Sci; 2005 Mar; 118(Pt 5):901-15. PubMed ID: 15713748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
    Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
    PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
    Roush WR; González FV; McKerrow JH; Hansell E
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.